News on immunohistochemistry and other tissue-based testing methods.
The team will combine Akoya's Vectra Polaris system with Precision for Medicine's Apostream tool to validate companion diagnostics and assess drug efficacy.
The acquisition of immunohistochemistry services provider QualTek will augment Discovery's existing histopathology services, the company said.
The firm's tool combines enzymatic and mechanical disruption to produce viable and accurate products for downstream single-cell applications.
The companies will work with collaborators at Stockholm University to integrate their respective technologies for in situ sequencing and tissue processing.
The assay examine phenotypic behaviors of isolated cancer cells from biopsies at initial diagnosis.
